Advertisement
News
Subscribe to MDT Magazine News

Stealthy AtheroMed Raises $6M for Peripheral Atherectomy Device

April 4, 2013 12:24 pm | by Mass Device | Comments

AtheroMed said it's raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings. The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.

TOPICS:

MedFocusCapital Partners Announces See.Hear.Live.Better! Alliance

April 4, 2013 9:07 am | by PR Newswire | Comments

SARASOTA, Fla., April 4, 2013 /PRNewswire/ -- MedFocusCapital Partners, Inc., an innovator in the eye care industry, announces See.Hear.Live.Better!, an alliance of healthcare service providers backed by leading product manufacturers, all focused on improving the quality of life through...

TOPICS:

VWR International, LLC Acquires Basan UK Limited

April 4, 2013 9:05 am | by PR Newswire | Comments

RADNOR, Pa., April 4, 2013 /PRNewswire/ -- VWR International, LLC, a global provider of laboratory supplies, equipment and services announced today the acquisition of Basan UK Limited, a leading distributor of cleanroom products and services.  VWR enables science globally by...

Advertisement

Syneron Launches its Proprietary Sublative Technology for Acne Scars

April 4, 2013 9:01 am | by The Associated Press | Comments

Syneron Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device company, announced today that it will begin the market launch of its proprietary Sublative technology for the removal or modification of the appearance of acne scars. The acne scar treatment is available on all of the...

TOPICS:

CryoLife Receives FDA Clearance For Next Generation HeRO Device

April 4, 2013 8:34 am | by PR Newswire | Comments

ATLANTA, April 4, 2013 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a next generation HeRO...

First Patient Treated Worldwide with the new TomoEDGE™ Dynamic Jaws Technology

April 4, 2013 8:30 am | by PR Newswire | Comments

SUNNYVALE, Calif., April 4, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Heidelberg University Hospital, Germany, has treated the world's first patients with the new TomoEDGE™ Dynamic Jaws technology combined with VoLO™ Planning as part of its...

Rapid Increase In Sclerosant Use Will Drive Steady Expansion Of US Varicose Vein Treatment Device Market

April 4, 2013 8:00 am | by PR Newswire | Comments

TORONTO, April 4, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, growth in the United States market for varicose vein treatment devices will be driven largely by strong growth in the sclerotherapy...

TOPICS:

POSTPONED: April 5, 2013 Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

April 4, 2013 12:00 am | by U.S. Food & Drug Administration | Comments

The Food and Drug Administration (FDA) is postponing the meeting of the Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee scheduled for April 5, 2013.  The meeting was announced in the Federal Register of November 29, 2012 (77 FR 71195). The meeting is postponed because key participants were unavailable due to unforeseen scheduling conflicts.

TOPICS:
Advertisement

Diabetes: J&J Recalls OneTouch Verio IQ Glucose Meters over Failure to Warn at Extreme Levels

April 3, 2013 4:41 pm | by Mass Device | Comments

Healthcare giant Johnson & Johnson (NYSE:JNJ) recalled all lots of its Verio IQ glucose meters over concerns that the device will fail to warn a diabetic patient in the extremely rare case of a blood glucose level higher than 56.8 mmol/L, or 1023 milligrams per deciliter.

TOPICS:

Call for Abstracts Involving Technical and Clinical Advances

April 3, 2013 4:36 pm | by Implant Research Center of Drexel University | Comments

The organizers of the 6th International UHMWPE Meeting — University of Torino, Implant Research Center of Drexel University and Exponent — are inviting authors to submit presentation proposals on advancements in medical grade ultra-high-molecular-weight polyethylene (UHMWPE) technology and clinical joint replacement applications prior to May 1.

TOPICS:

The Heart and Vascular Center Bad Bevensen Treats First Patients in Germany With Hansen Medical's Magellan Robotic System

April 3, 2013 4:03 pm | by The Associated Press | Comments

Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that the Heart and Vascular Center Bad Bevensen has performed the first successful cases with the Magellan™ Robotic System in Germany. These cases were performed by Dr. Thomas Nolte, Director...

TOPICS:

Ten Startups Selected for DreamIt Health, Philadelphia's First Health Care Accelerator

April 3, 2013 3:45 pm | by The Associated Press | Comments

Independence Blue Cross (IBC), Penn Medicine and DreamIt Ventures today announced the 10 health care startup companies selected to participate in DreamIt Health, the first-ever Philadelphia-based health care accelerator. The 2013 DreamIt Health inaugural class will enter a...

FDA's New Global Cardiovascular Registry to Start with Transcatheter Heart Valves

April 3, 2013 3:26 pm | by Mass Device | Comments

The FDA plans to launch a global cardiovascular medical device registry, with initial efforts to focus on coordinated efforts to monitor transcatheter heart valve technology. The federal watchdog agency will host a public meeting later this month to discuss goals and strategies for organizing such an effort.

TOPICS:

Next-Generation Circulating Tumor Cell Test Demonstrates High Efficiency and Accuracy in New Study

April 3, 2013 2:45 pm | by Bio-Medicine.Org | Comments

RARITAN, N.J. , April 3, 2013 /- Veridex, LLC (Veridex) announced today that the first study of the company's next-generation circulating tumor cell (CTC) technology, developed in collaboration with researchers at Massachusetts General Hospital (MGH), has been published in Science Translational Medicine .  The collaboration, initially announced in January 2011, has led to t...

TOPICS:

Device Finds Stray Cancer Cells in Patients’ Blood

April 3, 2013 2:15 pm | by Massachusetts Institute of Technology | Comments

Doctors typically diagnose cancer via a biopsy, which can be invasive and expensive. A better way to diagnose the disease would be to detect telltale tumor cells floating in the bloodstream, but such a test has proved difficult to develop because stray cancer cells are rare, and it’s difficult to separate them from the mélange of cells in circulation.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading